FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

ROCHE AMPLICHIP CYP450 TEST

K Number: K043576 · Decision Jan 10, 2005
Classifications
1
FEI Numbers
3
Registration Numbers
3
Same Product Code
10
Applicant Total
51
Review Days
14

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
ROCHE AMPLICHIP CYP450 TEST
K Number
K043576
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.3360
Medical Specialty
Clinical Toxicology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Roche Molecular Systems, Inc.
Date Received
December 27, 2004
Decision Date
January 10, 2005
Product Code
NTI
Advisory Committee
Clinical Toxicology
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NTI Drug Metabolizing Enzyme Genotyping Systems

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (NTI), ordered by most recent decision date.

View all

Other Clearances by Roche Molecular Systems, Inc.

K Number Device Name
K253756 cobas liat CT/NG nucleic acid test
K253759 cobas liat CT/NG/MG nucleic acid test
K243753 cobas liat Bordetella panel nucleic acid test
K252484 cobas HCV
K252481 cobas CMV
K243455 cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems
K243863 Opulus™ Lymphoma Precision
K243400 cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test
K243406 cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test
K243346 cobas liat SARS-CoV-2 v2 nucleic acid test
Search all 51 clearances from Roche Molecular Systems, Inc. →